Skip to main content

Minimally Invasive Splenectomy for Oncological Diseases of the Spleen

  • Chapter
  • First Online:
Minimally Invasive Surgery for Upper Abdominal Cancer

Abstract

Laparoscopic splenectomy (LS) has become the gold standard procedure for the treatment of benign hematological disorders not associated with splenomegaly, such as idiopathic thrombocytopenic purpura (ITP) [1, 2]. The great advances in minimally invasive surgery (MIS) that have been made over the last two decades did also benefit patients suffering from hematological malignant diseases However, this patients usually develop splenomegaly and the endoscopic manipulation of bulky organs is technically more challenging, and retrieval of the specimen may prove difficult. Splenomegaly was initially considered a contraindication for LS, thus, many malignant hematological diseases which are associated with an enlarged spleen were traditionally reserved for open splenectomy (OS) with its associated increased morbidity. Improvements and refinement of LS techniques have resulted in the ability to remove an enlarged spleen using the laparoscopic approach and preserving all the advantages of the MIS [3–5].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Park A, Targarona EM, Trias M. Laparoscopic surgery of the spleen: state of the art. Langenbecks J Surg. 2001;386:230–9.

    Article  CAS  Google Scholar 

  2. Habermalz B, Sauerland S, Decker G, et al. Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2008;22:821–48.

    Article  CAS  PubMed  Google Scholar 

  3. Weiss 3rd CA, Kavic SM, Adrales GL, et al. Laparoscopic splenectomy: what barriers remain? Surg Innov. 2005;12:23–9.

    Article  PubMed  Google Scholar 

  4. Kaban GK, Czerniach DR, Cohen R, et al. Hand-assisted laparoscopic splenectomy in the setting of splenomegaly. Surg Endosc. 2004;18:1340–3.

    Article  CAS  PubMed  Google Scholar 

  5. Targarona EM, Balagué C, Trias M. Is the laparoscopic approach reasonable in cases of splenomegaly? Semin Laparosc Surg. 2004;11:185–90.

    PubMed  Google Scholar 

  6. Kant JA, Hubbard SM, Longo DL, et al. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin lymphoma. J Clin Oncol. 1986;4:1419–20.

    Article  Google Scholar 

  7. Moulin-Romsee G, Hindié E, Cuenca X, et al. (18)F FDG PET/CT bone/bone marrow findings in Hodgkin’s lymphoma may circumvent the use of bone marrow thephine biopsy at diagnosis staging. Eur J Nucl Med Mol Imaging. 2010;37:1095–105.

    Article  PubMed  Google Scholar 

  8. Jost LM, Stahel RA, ESMO Guideline Task Force. ESMO minimal clinical recommendation for diagnosis, treatment and follow up of Hodgkin’s disease. Ann Oncol. 2005;16:i54–5.

    Article  PubMed  Google Scholar 

  9. Multani P, White CA, Grillo A. Non-Hodgkin lymphoma: review of conventional treatments. Curr Pharm Biotechnol. 2001;2:279–91.

    Article  CAS  PubMed  Google Scholar 

  10. Palma M, Kokhaei P, Lundin J, et al. The biology and treatment of chronic lymphocytic leukemia. Ann Oncol. 2006;17:x144–54.

    Article  PubMed  Google Scholar 

  11. NCCN. Clinical practice guidelines in oncology™. Non-Hodgkin’s Lymphoma. V.3.2007. www.nccn.org.

  12. Hunter T. Treatment for chronic myelogenous leukemia: the long road to imatinib. J Clin Invest. 2007;117:2036–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Hehlmann R, Hochhaus A, Baccarani M. European leukemia net. Chronic myeloid leukaemia. Lancet. 2007;370:342–50.

    Article  CAS  PubMed  Google Scholar 

  14. Arana-Yi C, Quintás-Cardama A, Giles F, et al. Advances in the therapy of chronic idiopathic myelofibrosis. Oncologist. 2006;11:929–43.

    Article  CAS  PubMed  Google Scholar 

  15. Dingli D, Mesa RA, Tefferi A. Myelofibrosis with myeloid metaplasia: new developments in pathogenesis and treatment. Intern Med. 2004;43:540–7.

    Article  CAS  PubMed  Google Scholar 

  16. Lopez Monclova J, Targarona Soler E, Peraza Solis Y, et al. Laparoscopic approach for isolated splenic metastasis: comprehensive literature review and report of 6 cases. Surg Laparosc Endosc Percutan Tech. 2013;23:21–4.

    Article  PubMed  Google Scholar 

  17. Heniford T, Walsh M. Laparoscopic splenectomy for malignant diseases. In: Greene FL, Heniford B, editors. Minimally invasive cancer management. 1st ed. NY: Springer; 2001. p. 143–55.

    Chapter  Google Scholar 

  18. Comperat E, Bardier-Dupas A, Camparo P, et al. Splenic metastases: clinicopathologic presentation, differential diagnosis, and pathogenesis. Arch Pathol Lab Med. 2007;131:965–9.

    PubMed  Google Scholar 

  19. Iwase K, Higaki J, Yoon HE, et al. Splenic artery embolization using contour emboli before laparoscopic or laparoscopically assisted splenectomy. Surg Laparosc Endosc Percutan Tech. 2002;12:331–6.

    Article  PubMed  Google Scholar 

  20. Martin Arnau B, Turrado Rodriguez V, Tartaglia E, et al. Impact of preoperative platelet count on perioperative outcome after laparoscopic splenectomy for idiopathic thrombocytopenic purpura. Cir Esp. 2016;94:399–403.

    Article  PubMed  Google Scholar 

  21. Rodriguez-Otero Luppi C, Targarona Soler EM, Balague Ponz C, et al. Clinical, anatomical, and pathological grading score to predict technical difficulty in laparoscopic splenectomy for non-traumatic diseases. World J Surg. 2017,41:439–448, doi:10.1007/s00268–016-3683-y.

  22. Targarona EM, Balagué C, Trias M. Hand-assisted laparoscopic splenectomy. Semin Laparosc Surg. 2001;8:126–34.

    Article  CAS  PubMed  Google Scholar 

  23. Targarona EM, Balague C, Cerdan G, et al. Hand-assisted laparoscopic splenectomy (HALS) in cases of splenomegaly: a comparison analysis with conventional laparoscopic splenectomy. Surg Endosc. 2002;16:426–30.

    Article  CAS  PubMed  Google Scholar 

  24. Targarona EM, Cerdan G, Trias M. Complications of laparoscopic splenectomy. Probl Gen Surg. 2002;19:72–9.

    Article  Google Scholar 

  25. Ikeda M, Sekimoto M, Takiguchi S, et al. High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg. 2005;24:208–16.

    Article  Google Scholar 

  26. Targarona EM. Portal vein thrombosis after laparoscopic splenectomy: the size of the risk. Surg Innov. 2008;15:266–70.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

1 Electronic Supplementary Materials

Hand assisted splenectomy (HALS) (MPG 23982 kb)

Hand assisted splenectomy (HALS). Targarona (MP4 374061 kb)

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Monclova, J.L., Luppi, C.R., Targarona Soler, E.M. (2017). Minimally Invasive Splenectomy for Oncological Diseases of the Spleen. In: Cuesta, M. (eds) Minimally Invasive Surgery for Upper Abdominal Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-54301-7_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-54301-7_32

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-54300-0

  • Online ISBN: 978-3-319-54301-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics